Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. | Nat Commun | 2024 | 38383600 | PubTator, text mining | PubMed |
| TOP1 and R-loops facilitate transcriptional DSBs at hypertranscribed cancer driver genes. | iScience | 2024 | 38375218 | PubTator, text mining | PubMed |
| Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC. | Ann Oncol | 2024 | 38369013 | PubTator, text mining | PubMed |
| Leave-one-out-analysis (LOOA): web-based tool to predict influential proteins and interactions in aggregate-crosslinking proteomic data. | Bioinformation | 2024 | 38352912 | PubTator, text mining | PubMed |
| G-quadruplexes on chromosomal DNA negatively regulates topoisomerase 1 activity. | Nucleic Acids Res | 2024 | 38340342 | PubTator, text mining | PubMed |
| Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma. | BMC Complement Med Ther | 2024 | 38297292 | PubTator, text mining | PubMed |
| A human papillomavirus 16 E2-TopBP1 dependent SIRT1-p300 acetylation switch regulates mitotic viral and human protein levels. | bioRxiv | 2024 | 38293041 | PubTator, text mining | PubMed |
| Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives. | Int J Mol Sci | 2024 | 38279210 | PubTator, text mining | PubMed |
| Enhancing chemical synthesis: a two-stage deep neural network for predicting feasible reaction conditions. | J Cheminform | 2024 | 38268009 | PubTator, text mining | PubMed |
| The Influence of Graphene Oxide-Fe3O4 Differently Conjugated with 10-Hydroxycampthotecin and a Rotating Magnetic Field on Adenocarcinoma Cells. | Int J Mol Sci | 2024 | 38256006 | PubTator, text mining | PubMed |
| Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy. | Biomedicines | 2024 | 38255292 | PubTator, text mining | PubMed |
| Enzymatic Processing of DNA-Protein Crosslinks. | Genes (Basel) | 2024 | 38254974 | PubTator, text mining | PubMed |
| Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction. | J Enzyme Inhib Med Chem | 2024 | 38221785 | PubTator, text mining | PubMed |
| The enzymatic properties of Arabidopsis thaliana DNA polymerase λ suggest a role in base excision repair. | Plant Mol Biol | 2024 | 38217735 | PubTator, text mining | PubMed |
| Protein interaction networks in the vasculature prioritize genes and pathways underlying coronary artery disease. | Commun Biol | 2024 | 38216744 | PubTator, text mining | PubMed |
| Deficiency of TOP1MT enhances glycolysis through the stimulation of PDK4 expression in gastric cancer. | Cancer Metab | 2024 | 38200513 | PubTator, text mining | PubMed |
| Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. | Cell Commun Signal | 2024 | 38200509 | PubTator, text mining | PubMed |
| PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity. | Nat Commun | 2024 | 38191578 | PubTator, text mining | PubMed |
| Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma. | Eur J Med Chem | 2024 | 38185054 | PubTator, text mining | PubMed |
| Are you thinking what I'm thinking? Perspective-taking in a language game. | PLoS One | 2024 | 38180973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=18